BioSensics
BioSensics is a global leader in developing wearable sensors and digital health technologies for clinical trials, patient monitoring, and health assessment. Founded in 2007 by Harvard scientists, it has pioneered the use of wearable sensors in healthcare, creating innovative solutions for neurological and neuromuscular disorders, and supporting clinical research and trials worldwide. The company offers end-to-end solutions, including wearable sensors, software, algorithms, and comprehensive services, with over $50M in NIH funding to support its R&D programs. BioSensics actively collaborates with research institutions, healthcare providers, industry partners, and experts in caregiver support to advance digital health technologies, biomarkers, and caregiver well-being.
Industries
Nr. of Employees
small (1-50)
BioSensics
57 Chapel Street, Suite 200, Newton, MA 02458
Patents
Products
Wearable sensor for gait and balance assessment
An IMU-based wearable device designed for clinical gait and balance measurement in clinic and at-home settings; used in multiple clinical studies.
Precision actigraphy wearable for continuous activity and sleep monitoring
A long-battery, high-memory wearable for continuous measurement of physical activity, posture, transitions, sleep and falls with multi-parameter outputs.
Upper-limb monitoring wearable and analytic solution
Wearable sensor and algorithm suite for continuous assessment of upper-limb function and goal-directed movements during daily activities.
Multi-modal home assessment platform (motor, speech, cognition, ePRO)
A configurable digital-health platform offering a broad set of remote assessments across motor, cognitive and speech domains plus integrated ePRO/eCOA workflows for decentralized trials.
Speech data collection and biomarker analysis technology
A speech capture and analytics solution that standardizes speech data collection and computes multiple acoustic and cepstral biomarkers for clinical research.
Video-based biomarker capture and analysis tool
Tools for standardized video capture and automated extraction of facial and behavioral metrics used for remote assessment of visual signs.
Wearable sensor for gait and balance assessment
An IMU-based wearable device designed for clinical gait and balance measurement in clinic and at-home settings; used in multiple clinical studies.
Precision actigraphy wearable for continuous activity and sleep monitoring
A long-battery, high-memory wearable for continuous measurement of physical activity, posture, transitions, sleep and falls with multi-parameter outputs.
Upper-limb monitoring wearable and analytic solution
Wearable sensor and algorithm suite for continuous assessment of upper-limb function and goal-directed movements during daily activities.
Multi-modal home assessment platform (motor, speech, cognition, ePRO)
A configurable digital-health platform offering a broad set of remote assessments across motor, cognitive and speech domains plus integrated ePRO/eCOA workflows for decentralized trials.
Speech data collection and biomarker analysis technology
A speech capture and analytics solution that standardizes speech data collection and computes multiple acoustic and cepstral biomarkers for clinical research.
Video-based biomarker capture and analysis tool
Tools for standardized video capture and automated extraction of facial and behavioral metrics used for remote assessment of visual signs.
Services
Scientific consultation on study design, endpoint selection, and protocol documents for trials incorporating remote digital measures.
Development and validation of signal-processing pipelines and machine-learning models for sensor, speech and video data.
End-to-end operational services including device provisioning, remote data collection support, and study logistics for decentralized or hybrid trials.
Curated access to a centralized repository of anonymized digital measures and study datasets to support research and secondary analyses.
Collaborative product development and academic partnerships to integrate digital measures into clinical research and commercialization pathways.
Advisory and implementation services to integrate caregiver-focused features—secure video communication, task management, medication reminders and caregiver assessment tools—into clinical or care-coordination workflows.
Scientific consultation on study design, endpoint selection, and protocol documents for trials incorporating remote digital measures.
Development and validation of signal-processing pipelines and machine-learning models for sensor, speech and video data.
End-to-end operational services including device provisioning, remote data collection support, and study logistics for decentralized or hybrid trials.
Curated access to a centralized repository of anonymized digital measures and study datasets to support research and secondary analyses.
Collaborative product development and academic partnerships to integrate digital measures into clinical research and commercialization pathways.
Advisory and implementation services to integrate caregiver-focused features—secure video communication, task management, medication reminders and caregiver assessment tools—into clinical or care-coordination workflows.
Expertise Areas
- Digital biomarker development
- Wearable sensor design and validation for gait, balance and upper-limb monitoring
- Remote patient monitoring and decentralized clinical trials
- Speech and video biomarker analytics
Key Technologies
- Inertial measurement unit (IMU)-based wearable sensors
- Precision actigraphy
- Upper-limb motion sensing
- Speech signal processing (waveform, spectral, cepstral analysis)
News & Updates
BioSensics will showcase FDA-listed wearable devices and digital health technologies for monitoring motor, speech, and cognitive functions in clinic and at home, with presentations and booth in San Diego, CA.
BioSensics will sponsor and present products including PAMSys for monitoring physical activity and fatigue in myasthenia gravis, in Dallas, TX.
Publication of a clinical study establishing the validity of wearable sensors and machine learning in HD.
BioSensics completed a natural history study on digital biomarkers for dementia and Alzheimer's, with presentations at CTAD.
Published study on remote gait assessment in PSP and Parkinson's using BioDigit and LEGSys.
Launch of BioDigit Speech for speech data collection and analysis in clinical trials, supported by NIH.
BioSensics will showcase FDA-listed wearable devices and digital health technologies for monitoring motor, speech, and cognitive functions in clinic and at home, with presentations and booth in San Diego, CA.
BioSensics will sponsor and present products including PAMSys for monitoring physical activity and fatigue in myasthenia gravis, in Dallas, TX.
Publication of a clinical study establishing the validity of wearable sensors and machine learning in HD.
BioSensics completed a natural history study on digital biomarkers for dementia and Alzheimer's, with presentations at CTAD.
Published study on remote gait assessment in PSP and Parkinson's using BioDigit and LEGSys.
Launch of BioDigit Speech for speech data collection and analysis in clinical trials, supported by NIH.